A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Medical Genetics

• Publication date

  1989-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jmg.26.11.712PMID 2511319PMCID PMC1015741
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multipoint linkage analysis in neurofibromatosis type I: an international collaboration.

  1989cited by this paper
• A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

  1989cited by this paper
• Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

  1988cited by this paper
• Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

  1988cited by this paper
• Neurofibromatosis in children with soft tissue sarcoma.

  1988cited by this paper
• Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales

  1988cited by this paper
• Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17

  1988cited by this paper
• Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes.

  1987cited by this paper
• Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

  1987cited by this paper
• Ophthalmic manifestations of neurofibromatosis.

  1987cited by this paper
• Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.

  1987cited by this paper
• Iris hamartomata as diagnostic criterion in neurofibromatosis.

  1986cited by this paper
• Iris (Lisch) nodules in neurofibromatosis

  1986cited by this paper
• Linkage analysis of peripheral neurofibromatosis (Von Recklinghausen disease) and chromosome 19 markers linked to myotonic dystrophy.

  1986cited by this paper
• Prevalence of congenital-nevus-like nevi, nevi spili, and café au lait spots.

  1985cited by this paper
• Von Recklinghausen neurofibromatosis: II. Incidence of optic gliomata.

  1985cited by this paper
• Gliomas in neurofibromatosis: a series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas.

  1985cited by this paper
• Malignancy in neurofibromatosis.

  1985cited by this paper
• von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

  1984cited by this paper
• Brief clinical report: aqueductal stenosis leading to hydrocephalus--an unusual manifestation of neurofibromatosis.

  1983cited by this paper
• “Neurofibromatosis (Von Recklinghausen's disease): A clinical‐psychiatric and genetic study.” Birgitta Samuelsson, M. D. Psychiatric Department III, University of Göteborg, Lilliagen's Hospital, Göteborg, Sweden

  1982cited by this paper
• Café-au-lait spots in schoolchildren.

  1982cited by this paper
• Neurofibromatosis : (v. Recklinghausen's disease) : a clinical-psychiatric and genetic study

  1981cited by this paper
• Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata.

  1981cited by this paper
• Congenital pseudarthrosis of the tibia.

  1981cited by this paper
• Spine deformity in neurofibromatosis. A review of one hundred and two patients.

  1979cited by this paper
• Phaeochromocytomas in 72 patients: Clinical and diagnostic features, treatment and long term results

  1979cited by this paper
• Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

  1979cited by this paper
• Cerebrovascular Changes in Neurofibromatosis

  1978cited by this paper
• Neurofibromatosis and childhood leukemia.

  1978cited by this paper
• Pulsating enophthalmos and choroidal hamartomas: two rare stigmata of neurofibromatosis.

  1977cited by this paper
• Neurofibromatous scoliosis. Natural history and results of treatment in thirty-seven cases.

  1976cited by this paper
• Von Recklinghausen's Disease: A Clinicopathological Study

  1972cited by this paper
• A clinical, pathological, and genetic study of multiple neurofibromatosis

  1956cited by this paper
• CLINICAL AND GENETIC INVESTIGATIONS INTO TUBEROUS SCLEROSIS AND RECKLINGHAUSENʼS NEUROFIBROMATOSIS

  1954cited by this paper
• Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis; contribution to elucidation of interrelationship and eugenics of the syndromes.

  1951cited by this paper
• [Congenital pseudoarthrosis of the tibia].

  1949cited by this paper
• Congenital pseudo-arthrosis of the tibia; the findings in one case and a suggestion as to possible etiology and treatment.

  1949cited by this paper
• A Case of Congenital Deformity

  1897cited by this paper
• A Case of Congenital Deformity

  1859cited by this paper

• Small bowel obstruction from jejunal gastrointestinal stromal tumour in a young adult with neurofibromatosis type 1: a case report

  2026cites this paper
• Utilization of PET/MR Imaging and PET/CT in Uncommon Pediatric Disease.

  2026cites this paper
• A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification

  2025cites this paper
• RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity

  2025cites this paper
• Therapeutic drug monitoring of selumetinib in pediatrics: a combined LC-MS/MS and LC-HRMS approach

  2025cites this paper
• Inhibition of Cxcr4 chemokine receptor signaling improves habituation learning and increases cAMP-PKA signaling in a zebrafish model of Neurofibromatosis type 1

  2025cites this paper
• Six at Sixty. Malignant peripheral nerve sheath tumours in NF1: 20-year review of a highly cited paper

  2024cites this paper
• Genotype–Phenotype Correlation in Neurofibromatosis Type 1: Evidence for a Mild Phenotype Associated with Splicing Variants Leading to In-Frame Skipping of NF1 Exon 24 [19a]

  2024influential citation
• Whole-body MRI-based long-term evaluation of pediatric NF1 patients without initial tumor burden with evidence of newly developed peripheral nerve sheath tumors

  2024cites this paper
• Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI

  2024influential citation
• Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 – intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imaging

  2024cites this paper
• A single-center case study series assessing the effect of selumetinib use in patients with neurofibromatosis-related plexiform neurofibromas.

  2024cites this paper
• Familial schwannomatosis carrying LZTR1 variant p.R340X with brain tumor: A case report

  2024cites this paper
• Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management

  2024cites this paper
• p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs

  2023cites this paper
• A new era for myelin research in Neurofibromatosis type 1

  2023cites this paper
• Mandibular symmetry on posterior-anterior cephalograms of neurofibromatosis type 1 patients with facial plexiform neurofibroma

  2023influential citation
• Neurofibromatosis type 1-associated plexiform neurofibromas of the neck: topography of lesions and surgical treatment data of 69 patients

  2023cites this paper
• RAS Signaling Gone Awry in the Skin: The Complex Role of RAS in Cutaneous Neurofibroma Pathogenesis, Emerging Biological Insights.

  2023cites this paper
• Neurofibromatosis‐ and schwannomatosis‐associated tumors: Approaches to genetic testing and counseling considerations

  2023cites this paper
• Identification of an NF1 Microdeletion with Optical Genome Mapping

  2023cites this paper
• Neurofibromatosis Type 1-Associated Plexiform Neurofibromas of the Face and Adjacent Head Regions: Topography of Lesions and Surgical Treatment Data of 179 Patients

  2023cites this paper
• CASE SERIES

  2022cites this paper
• Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1

  2022cites this paper
• Spinal screening, malignancy, medical therapy, and surgical correction of deformity in pediatric patients with neurofibromatosis type 1: a systematic review

  2022cites this paper
• Current concepts of neurofibromatosis type 1: pathophysiology and treatment

  2022cites this paper
• Version française des critères révisés des diagnostics de neurofibromatose de type 1, de syndrome de Legius et de leurs formes mosaïques

  2022cites this paper
• Case Report: Differential diagnosis for tuberous sclerosis and neurofibromatosis type 1 diagnostic pitfall of aggressively enlarged right upper limb

  2022cites this paper
• Das NF1‐Mikrodeletions‐Syndrom: Die frühzeitige genetische Diagnose erleichtert den Umgang mit einer klinisch definierten Erkrankung

  2022cites this paper
• The NF1 microdeletion syndrome: early genetic diagnosis facilitates the management of a clinically defined disease

  2022cites this paper
• A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort

  2022cites this paper
• Papillary thyroid carcinoma associated with glioblastoma in a neurofibromatosis 1 patient: An unusual and rare combination of multiple primary malignancies

  2022cites this paper
• Clinical and molecular features of neurofibromatosis types 1 and 2: a review of the literature

  2022cites this paper
• A case of intramandibular neurofibroma resembling a radicular cyst in a neurofibromatosis type 1 patient

  2021cites this paper
• Neurofibromin expression by normal salivary glands

  2021cites this paper
• US Food and Drug Administration regulatory updates in neuro-oncology

  2021cites this paper
• Severe Phenotype in Patients with Large Deletions of NF1

  2021cites this paper
• Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth

  2021cites this paper
• Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI

  2021cites this paper
• Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review

  2021cites this paper
• Implications of mosaicism in variant interpretation: A case of a de novo homozygous NF1 variant.

  2021cites this paper
• Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI.

  2021cites this paper
• Challenges in the diagnosis of neurofibromatosis type 1 (NF1) in young children facilitated by means of revised diagnostic criteria including genetic testing for pathogenic NF1 gene variants

  2021influential citation
• Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

  2020cites this paper
• Clinical Cancer Genetics

  2020cites this paper
• Computed Tomography–Based Differentiation of Benign and Malignant Craniofacial Lesions in Neurofibromatosis Type I Patients: A Machine Learning Approach

  2020cites this paper
• A narrative review of the role of fibroblasts in the growth and development of neurogenic tumors

  2020cites this paper
• The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities

  2020cites this paper
• Cutaneous manifestations in neurofibromatosis type 1.

  2020cites this paper
• Neurofibromatosis Type 1: New Developments in Genetics and Treatment.

  2020cites this paper
• The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1

  2020cites this paper
• Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1

  2019cites this paper
• The impact of host immune cells on the development of neurofibromatosis type 1: The abnormal immune system provides an immune microenvironment for tumorigenesis

  2019cites this paper
• Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in neurofibromatosis type 1

  2019cites this paper
• A Guide to Pheochromocytomas and Paragangliomas.

  2019cites this paper
• Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside

  2019cites this paper
• The Diagnosis and Management of Neurofibromatosis Type 1.

  2019cites this paper
• Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.

  2019cites this paper
• Peranan Radiologi dan Radioterapi pada Penatalaksanaan Malignant Peripheral Nerve Sheath Tumor

  2019cites this paper
• Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation

  2019cites this paper
• Human Mutation

  2019cites this paper
• Neurofibromatosis type 1 of the child increases birth weight

  2019cites this paper
• Neurofibromatosis Type 1: A Population-Based Study.

  2019cites this paper
• Neurofibromatosis type 1.

  2018cites this paper
• Expanding the clinical phenotype of individuals with a 3-bp in-frame deletion of the NF1 gene (c.2970_2972del): an update of genotype–phenotype correlation

  2018cites this paper
• Neurofibromatosis and type-1 diabetes in a seven-year-old child: A rarecombination.

  2018cites this paper
• Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1

  2018cites this paper
• Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging

  2018cites this paper
• Optic Pathway Gliomas in Neurofibromatosis Type 1

  2018cites this paper
• Neurofibromin (NF1) genetic variant structure–function analyses using a full‐length mouse cDNA

  2018cites this paper
• Neurofibromatosis type 1 (NF1): Exploring parent’s experiences of using a customisable information sharing resource (The NF File) using thematic analysis

  2017cites this paper
• Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848

  2017cites this paper
• Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study

  2017cites this paper
• Breast Cancer Genetics

  2017cites this paper
• Brain Tumors, Intraocular and Orbital Tumors

  2016cites this paper
• Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors

  2016cites this paper
• A case report of neurofibromatosis Type 1 – plexiform variant

  2016influential citation
• The effect of parental age on the presence of de novo mutations – Lessons from neurofibromatosis type I

  2016cites this paper
• A CLINICOPATHOLOGICAL STUDY OF NEUROFIBROMATOSIS TYPE 1 IN A TERTIARY LEVEL CARE CENTRE

  2016cites this paper
• Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients

  2016cites this paper
• Distinctive Cancer Associations in Patients With Neurofibromatosis Type 1.

  2016cites this paper
• Malignant peripheral nerve sheath tumors of the head and neck: Demographics, clinicopathologic features, management, and treatment outcomes.

  2015cites this paper
• Neurofibromatosis type 1.

  2015cites this paper
• Neurofibromatosis of the Head and Neck: Classification and Surgical Management

  2015cites this paper
• Genetics of Bladder Malignant Tumors in Childhood

  2015cites this paper
• Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).

  2015cites this paper
• High Incidence of Noonan Syndrome Features Including Short Stature and Pulmonic Stenosis in Patients carrying NF1 Missense Mutations Affecting p.Arg1809: Genotype–Phenotype Correlation

  2015cites this paper
• [Phenotypic and genetic features in neurofibromatosis type 1 in children].

  2015cites this paper
• Características fenotípicas y genéticas en la neurofibromatosis tipo 1 en edad pediátrica

  2015cites this paper
• Multidisciplinary approach for evaluation of neurocutaneous disorders in children in Sohag University Hospital, Upper Egypt

  2015cites this paper
• [Management of craniofacial type 1 neurofibromatosis].

  2015cites this paper
• A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor

  2015cites this paper
• Preclinical assessments of the MEK inhibitor PD‐0325901 in a mouse model of neurofibromatosis type 1

  2015cites this paper
• A novel NF1 frame-shift mutation (c.702_703delGT) in a Chinese family with neurofibromatosis type 1.

  2014cites this paper
• Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directions

  2014cites this paper
• Population-specific differences in gene conversion patterns between human SUZ12 and SUZ12P are indicative of the dynamic nature of interparalog gene conversion

  2014cites this paper
• Association of Mal de Meleda with Neurofibromatosis Type 1, in 15-year Old Caucasian Female with Familial History of Neurofibromatosis Type 1. Case Report and Review of the Literature

  2014cites this paper
• Chapter 121 – The Phakomatoses

  2013cites this paper
• Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma

  2013influential citation
• NF 1-associated pilocytic astrocytoma Somatic neurofibromatosis type 1 ( NF 1 ) inactivation characterizes Material Supplemental

  2013influential citation